ArticleRadiology case reports2026
Acute left ovarian vein thrombosis following percutaneous renal biopsy: A case report.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian vein thrombosis is a previously unreported complication of percutaneous renal biopsy. We present the case of a 42-year-old female with systemic lupus erythematosus who developed acute left ovarian vein thrombosis three days after ultrasound-guided left renal biopsy performed to evaluate new-onset proteinuria. The patient presented to the emergency department with lower abdominal pain, generalized weakness, fatigue, and heart palpitations. Computed tomography with intravenous contrast revealed an anatomic variant left ovarian vein posterolateral to the left kidney with acute thrombosis. The pathogenesis is attributed to endothelial injury of the ovarian vein during the biopsy procedure and increased risk of thrombosis due to lupus-associated hypercoagulability. After exclusion of hemorrhagic and other common post-biopsy complications, the patient was managed with a three-month course of apixaban following vascular surgery consultation and was discharged in stable condition. This case underscores the importance of preprocedural vascular mapping to identify anatomical variants that may alter procedural risk and predispose to thrombotic complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.